I made a study of the drug economy on the use of growth factors in trauma entitled "Comparative analysis of the costs and cost / effectiveness of the treatment of non-unions posttraumatic persistent tibia with autologous iliac crest or Osigraft® (Eptotermin alpha, rhBMP-7, RhoW-1).

I am responsible for Project Scientific articulated for the development of specific DRG inherent to the use of biotechnology in the field of orthopedics and traumatology.

I am responsible for the group's European and Italian for the treatment of post-traumatic lesion and revision prosthetic complex with the use of prostheses from large resection.

I am responsible for the Italian group for the treatment of limb fractures by osteosynthesis with fixation Carbon.

I am responsible for the Italian group for osteosynthesis of fractures in children (Orthopediatrics).

It is currently being a comparative study on the efficacy of growth factors (rh-BMP-7) compared to autologous bone graft from the iliac crest in the treatment of 150 pseudoarthrosis and loss of substance of the long bones.

It is currently being approved a research project to Ban Ministerial 2011/2012 with a retrospective and prospective on the use of growth factors (rh-BMP-7) compared Autologous bone grafting in the treatment of nonunion of long bones called "Observational Retrospective Study crossed to a Clinical Prospective Study to assess the clinical effectiveness of rhBMP-7 (eptotermin alfa) in long-bone non-unions and critical bone defects."